PolyPeptide Group AG engages in the business of development, manufacturing, and marketing of peptide- and oligonucleotide-based compounds for use in the pharmaceutical and related research industries. The company is headquartered in Baar, Zug and currently employs 1,366 full-time employees. The company went IPO on 2021-04-29.
Follow-Up Questions
What is the price performance of PLYGF stock?
The current price of PLYGF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for PolyPeptide Group AG?
PolyPeptide Group AG belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is PolyPeptide Group AG market cap?
PolyPeptide Group AG's current market cap is $0
Is PolyPeptide Group AG a buy, sell, or hold?
According to wall street analysts, 7 analysts have made analyst ratings for PolyPeptide Group AG, including 2 strong buy, 7 buy, 1 hold, 1 sell, and 2 strong sell
